Cellectis (CLLS) Tops Q2 EPS by 25c

Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.19), $0.25 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2 million versus the consensus estimate of $4.48 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• SpaceX: New Street Research sees 22% upside from proposed IPO price
• After-Hours Stock Movers: ADBE, MRVL, RH, RKLB, RDW, SPCE, ASTS
• RH (RH) Tops Q1 EPS by 12c